揭开沉默的威胁:COVID-19和心肌损伤
1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan 430030, China.
Pharmacology & therapeutics
|June 29, 2025
概括
COVID-19可能会导致显著的心肌损伤,影响30-50%的患者并导致死亡. 本次审查强调了识别和治疗COVID-19和疫苗引起的心脏并发症的重要性.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- COVID-19,最初以呼吸系统症状而闻名,越来越多地显示心脏参与.
- 心肌损伤影响30-50%的COVID-19患者,是死亡的重要原因,即使没有严重的肺部疾病.
- 接种疫苗后心肌炎是一个日益严重的全球性问题,其特点是严重的炎症和潜在的致命性.
研究的目的:
- 为了提高人们对COVID-19相关的心肌损伤的认识.
- 为管理COVID-19和疫苗引起的心脏并发症提供证据和经验.
- 审查COVID-19相关心肌损伤的发病,临床特征,诊断和治疗.
主要方法:
- 关于COVID-19和心肌损伤的研究的综合文献综述.
- 对致病发生,临床症状,诊断和治疗的研究进行分析.
- 重点是雷宁- ангиотензин系统 (RAS) 抑制剂,特别是 ангиотензинII受体阻断剂 (ARBs) 的作用.
主要成果:
- 心肌损伤是COVID-19的一个普遍而严重的并发症.
- 心脏干扰可能是COVID-19患者的主要死亡原因.
- 心肌损伤和心肌炎是可以检测和治疗的疾病.
结论:
- 心肌损伤是COVID-19及其长期影响的一个关键方面.
- 早期检测和管理对于患有COVID-19或疫苗心脏并发症的患者至关重要.
- RAS抑制剂,特别是ARBs,在控制心肌损伤方面发挥着至关重要的作用.
相关概念视频
01:14Myocarditis III: Medical Management
18
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
18
01:21Myocarditis I: Introduction
35
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
35
01:27Myocarditis II: Clinical Features and Diagnostic Tests
32
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
32
01:22Myocarditis IV: Nursing Management
36
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
36
01:30Acute Coronary Syndrome I: Introduction
81
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
81
01:28Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32